EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS091-00597 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr1:17287630-17288650 
Target genes
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF16MA0741.1chr1:17287678-17287689GCCCCGCCCCC+6.02
KLF5MA0599.1chr1:17287678-17287688GCCCCGCCCC+6.02
NKX2-5MA0063.2chr1:17287864-17287874CTCAAGTGGT-6.02
SP1MA0079.4chr1:17287675-17287690GAGGCCCCGCCCCCA+6.44
SP2MA0516.2chr1:17287765-17287782CTTAGCCCCGTCCCCTC+6.4
SP4MA0685.1chr1:17287675-17287692GAGGCCCCGCCCCCACA+6.56
SREBF1MA0595.1chr1:17288088-17288098GTGGGGTGAT-6.02
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_47084chr1:17287664-17287913Ovary
SE_69143chr1:17287003-17288001H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr11728802417288074
Number: 1             
IDChromosomeStartEnd
GH01I016960chr11728678117288206
Enhancer Sequence
GGCAGTGCCG CGCGCAGGGA AGGGGGGAGG TGGGCGGGCC GCACTGAGGC CCCGCCCCCA 60
CATGGCAGGG TGTTTTTGTT TTTGTTTTTG TTTTTTTTCA AGGAGCCCAC CACACCTCTC 120
CACTGAGGTC CACTTCTTAG CCCCGTCCCC TCACCGAGAC CCCTCCCTTC ACTGATCTGT 180
GCTTCTCAAG GGCGCTTCTT TTTTCTTTAG ACCAGGCCTC ATCTGTTTCC CGGGCTCAAG 240
TGGTCCTCCC TCCTCAGCCT CCTGAGTAGC TGGGACTACA GGTGTGCCAC CACGCCCAGC 300
TAATTTTTGT AGTTTTTGTG GAGACGGGGT CTCACTATGT TGCCCAGGCT GGTCTTAAAC 360
TCCTGGCCTC AAGCGATCCT CCTGTCTCAG CCTCTCAGGG TTGGGATTAG AGGCATGAGC 420
CACGGCACCC GGTCTAGGCC ACTTATTTTT TTGGGGAAGT GGGGTGATTC TTTTTTTTCA 480
ACTTTTGAGA CAGGATCTCA CTCTGTCACC TCAGTTGAAG TGCAGTAGTG TGATCTTGGC 540
TCCCTCTGCC TTGGCAGCCT GTGCCTCCTG GGCTCAAGTG ATTCTCCCAC CTCAACCTCC 600
TTTGTAGCTG AGACTACAGG TGTGCACTAC AATGTCTGCT TAATTTTTGT GTTTTTAGTA 660
GAGATGGGGT TTTGCCATAT TGCCCAGGCT AGTCTTGAAC TCCTGGACTC AAGCGATCCT 720
CCCACTGGGA TTACAGGCGT GAGCCACCGT GCCTTTCCTG GACCGGGGGC TGGAGGGCTC 780
TTAATGCCTT TGACTCCTTA TCTGATTTTC TGAGCTTCCA TCCTGCCATA TACTCCCACA 840
TACTTTCAGT CATCTCTAGG TTACTTAGGA TACCAAATAC AGCTAAGTGG AAATCTTACA 900
CTTGTTACAC TGTATTGTTT TTAATTATTC TTTTTGTTTT TTTTTGAGAT GGCGTCTTGC 960
TCTGTTGCCC AAGCTGGAGT GCAGTAGCAC GATCTCGGCT CACTGCAACC TCTGCCTCCT 1020